Fenwick & West LLP advised Chinook Therapeutics, Inc. on the deal. Chinook Therapeutics, Inc. (NASDAQ: KDNY), a clinical-stage biotechnology company developing precision medicines for kidney diseases,...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Health Gorilla on the deal. Health Gorilla, a leading provider of healthcare application programming interfaces, announced its $15 million Series B financing...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Armorblox on the deal. Armorblox, a cybersecurity innovator that helps organizations communicate more securely over email, announced its $30 million Series B...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Fortinet on the deal. Fortinet (Nasdaq: FTNT), a global leader in broad, integrated and automated cybersecurity solutions, announced its underwritten, registered public...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Madison Reed on the deal. Madison Reed, a San Francisco-based hair color company revolutionizing the way women color their hair, announced its...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised The Landing on the deal. The Landing, a social design platform that empowers everyone to create together, announced its $2.5 million seed...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Day One Biopharmaceuticals on the deal. Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company focused on accelerating new targeted therapies for children...
You must be a Standard 1 Year member to access this content.
